The Globe and Mail

Go to the Globe and Mail homepage

Jump to main navigationJump to main content

AdChoices

Biosyent Inc closed at $6.93.

This security is unchanged over the last five days and the last 52 weeks. This security has underperformed the S&P TSX by 4.81% during the last year.

Key company metrics

  • Trailing P/E26.62×
  • P/E 1 year forward20.67×
  • Forward PEGNegative, not meaningful
  • Indicated annual dividend--
  • Dividend yield--
  • Trailing EPS$0.26
Updated at previous session's close. Delayed by at least 15 minutes.

Profit

Net Profit (TTM)
+24.47%

Based on its net profit margin of 24.47%, Biosyent Inc is among the more effective companies in its industry at turning revenues into bottom line profit.
Company Books

S&P TSX0.00%Sector:HealthcareIndustry:Pharmaceuticals - Diversified

Latest Company News

View more News

Latest Press Releases

View more Press Releases
  • Income Statement
  • Balance Sheet
  • Cash Flow
Quarter | Annual
Q4/2015Q3/2015Q2/2015Q1/2015
Fiscal Quarter Endvalues in $ millions unless otherwise notedDec 31, 201512/31/2015Sep 30, 201509/30/2015Jun 30, 201506/30/2015Mar 31, 201503/31/2015
Revenue4543
Total other revenue--------
Total revenue4543
Gross profit3433
Total cost of revenue1111
Total operating expense3322
Selling / general / administrative2221
Research & development0000
Depreciation / amortization00----
Interest expense (income), net operating--------
Unusual expense (income)--------
Other operating expenses, total0000
Operating income1111
Interest income (expense), net non-operating--------
Gain (loss) on sale of assets--------
Other--------
Income before tax1211
Income after tax1111
Income tax, total0000
Net income1111
Total adjustments to net income--------
Net income before extra. items1111
Minority interest--------
Equity in affiliates--------
U.S. GAAP adjustment--------
Inc. avail. to common excl. extra. items1111
Inc. avail. to common incl. extra. items1111
Diluted net income1111
Dilution adjustment0000
Diluted weighted average shares14141414
Diluted EPS excluding extraordinary itemsvalue per share0.050.080.060.07
Dividends per sharevalue per share0.000.000.000.00
Diluted normalized EPSvalue per share0.050.080.060.07